Effects of Complex Training in Cricket Fast Bowlers
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Mar 4, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different training methods affect the performance of young male cricket fast bowlers. Specifically, it will compare "Complex training," which combines strength and explosive exercises, with "Conventional training," which focuses on traditional strength exercises. There will also be a control group that does not receive any special training. The study aims to see how these training methods impact physical fitness, bowling speed, and muscle strength over a period of 12 weeks.
To participate, interested bowlers must be male, aged 18 to 25, and play at a domestic level with a bowling speed of 115-130 km/h. They should have been actively playing cricket for at least the last six months and meet certain fitness criteria. Participants can expect to undergo various fitness tests at the beginning of the study, and again at six and twelve weeks, to evaluate changes in their performance. It’s important to note that participants with certain medical conditions or injuries, or those who have been training with weights recently, will not be eligible to join the study.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male bowlers between 18 - 25 years
- • Bowling speed 115-130 km/h
- • Same Run-up speed (20-25 km/h)
- • domestic teams
- • Active in game from last 6 months
- • Athletes with same 1 Repetition Maximum (Bench press and Leg press)
- • Athletes with same BMI category (18.5 - 24.9)
- Exclusion Criteria:
- • Red flags
- • Resistance training from last 6 months
- • Any disabling musculoskeletal injury
- • Glenohumeral Internal Rotation Deficit
- • Scapular Dyskinesia
- • Athletes taking prohibited drugs, Ergogenic aids
- • Any cardiovascular issue . Any systemic disease
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Muhammad Atif Javed, PP-DPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported